The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics—Definition, Current Advances, and Future Directions
With improved molecular characterization of clear cell renal cancer and advances in texture analysis as well as machine learning, diagnostic radiology is primed to enter personalized medicine with radiogenomics: the identification of relationships between tumor image features and underlying genomic...
Main Authors: | Nikhil Gopal, Pouria Yazdian Anari, Evrim Turkbey, Elizabeth C. Jones, Ashkan A. Malayeri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/3/793 |
Similar Items
-
Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine
by: Anahita Fathi Kazerooni, et al.
Published: (2021-11-01) -
Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions
by: Sari Khaleel, et al.
Published: (2022-04-01) -
MRI-Based Radiomics and Radiogenomics in the Management of Low-Grade Gliomas: Evaluating the Evidence for a Paradigm Shift
by: Ahmed Habib, et al.
Published: (2021-04-01) -
Radiogenomics and Its Research Progress in Renal Clear Cell Carcinoma
by: ZHANG Lu, et al.
Published: (2019-05-01) -
Regulatory and Ethical Issues in the New Era of Radiomics and Radiogenomics
by: Filippo Pesapane
Published: (2020-09-01)